Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma
Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
A phase II，single arm，open-label study to assess Maintenance Therapy of Chidamide in Patients
With Hepatitis B Virus（HBV）Positive Diffuse Large B-cell Lymphoma with complete response
after completion of prior chemotherapy